For some context, only about 200 out of 12,000 GLP-1 users developed alopecia during the study period (roughly 1.6%)
SUICIDAL IDEATION On Monday, July 10th, the European Medicines Agency said it would undertake a review into a number of obesity-treating and antidiabetic drugs after it was reported some patients experienced thoughts of suicide or self harm (CNBC)
Avoid skipping doses where possible - and if you do, follow the manufacturers guidelines
Using them together without medical oversight could lead to unpredictable and potentially harmful effects
Efficacy: By week 68, mean weight declined significantly more with semaglutide than with placebo (14.9% vs
However, the greater reduction of weight loss with semaglutide vs canagliflozin in the primary SUSTAIN 8 trial [17], when also taking into account the lack of statistical difference in body composition changes between treatments in this substudy, highlights the potential value of semaglutide in terms of weight management in individuals with uncontrolled type 2 diabetes on stable-dose metformin therapy